|
|
||||||||
|
FIGURE 9. 18F-DOPA PET in patient with suspected recurrent medullary thyroid cancer, based on increased calcitonin level. 18F-DOPA PET (A) and 18F-FDG PET (B) showed clear 18F-DOPA uptake in liver metastases in absence of 18F-FDG uptake. Small area of 18F-FDG uptake in left supraclavicular region was result of nonspecific muscle activity.
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY | THE JOURNAL OF NUCLEAR MEDICINE |